Verification of the Efficacy/safety of the Intratympanic Drug Delivery for Hearing Loss

NCT04766853 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Hearing Loss, Sudden
Hearing Loss, Ototoxic
Hearing Loss, Noise-Induced
Meniere Disease

Interventions

DRUG: Dexamethasone
DRUG: Hyaluronic acid

Sponsor

Seoul National University Hospital